Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

A woman with lupus and severe nerve damage improved with specific treatments.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Young adults with hair loss face higher risk of stiff arteries.

ASC-CM is more effective than EV for treating osteoarthritis.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Asthma may increase the risk of alopecia areata.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Increasing zinc intake improved skin and hair symptoms in a rare genetic disorder.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

SLE symptoms in Dubai are similar to those in other Arab and Western countries.